| pubmed-article:21613310 | pubmed:abstractText | To evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles of mavrilimumab, a human monoclonal antibody targeting the granulocyte-macrophage colony-stimulating factor receptor-?, in subjects with rheumatoid arthritis (RA). | lld:pubmed |
